A Longitudinal Computed Tomography Imaging in the Diagnosis of Gallbladder Cancer

Table 1

Patient characteristics.

	Gallbladder cancer	Gallbladder benign tumor	value
	()	()
Age	63 (42–77)	66 (19–82)	0.76
Gender (male)	15 (50%)	13 (54.2%)	0.76
Body mass index	22.9 (17.4–31.2)	22.7 (19.7–26.1)	0.62
White cell count (L)	6300 (4000–9100)	6850 (2500–16600)	0.21
Aspartate aminotransferase (IU/L)	31 (9–1688)	22 (11–174)	0.06
Alanine aminotransferase (IU/L)	30.5 (6–1044)	17.5 (6–162)	0.03
Lactic acid dehydrogenase (IU/L)	189 (109–1188)	168 (14–312)	0.13
Total bilirubin (mg/dL)	0.71 (0.34–13.96)	0.61 (0.12–3.27)	0.21
Alkaline phosphatase (IU/L)	222 (114–4399)	229 (115–1194)	0.93
-guanosine triphosphate (IU/L)	99 (33–1009)	65 (13–584)	<0.001
Cholinesterase (IU/L)	266 (93–458)	266 (166–450)	0.47
C-reactive protein (mg/dL)	0.5 (0.1–3.5)	0.5 (0.1–5.95)	0.88
Total cholesterol (mg/dL)	188 (144–324)	185 (133–266)	0.36
Prothrombin activity (%)	100 (79–100)	100 (73–100)	0.29
Carcinoembryonic antigen (ng/mL)	3.6 (0.8–254.6)	1.9 (0.3–5.1)	0.01
Carbohydrate antigen 19-9 (U/mL)	30.3 (0.1–9000)	40.0 (0.1–1056)	0.48

Data are expressed as medians with ranges.